Screener
Collegium Pharmaceutical, Inc. COLL EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from Collegium Pharmaceutical, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
FAQ
- What is Collegium Pharmaceutical, Inc.'s EV / EBITDA?
- Collegium Pharmaceutical, Inc. (COLL) reported EV / EBITDA of 3.7× in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s EV / EBITDA changed year-over-year?
- Collegium Pharmaceutical, Inc.'s EV / EBITDA increased by 49.9% year-over-year, from 2.4× to 3.7×.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s EV / EBITDA?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s EV / EBITDA has grown at a -10.4% compound annual growth rate (CAGR), from 7.1× to 4.1×.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.
Ask your AI about Collegium Pharmaceutical, Inc.'s ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude